1 The retractions came only weeks after BioMed Central.
In the past, the editor and editorial table of a journal knew both the scientific field it covered and the people employed in it, but it’s extremely difficult to become sufficiently well connected when both editors and submissions come from across the world. Having authors suggest the very best reviewers may therefore look like a good idea. In the aftermath of the latest scandals involving fake peer reviewers, many journals are determined to carefully turn off the reviewer-recommendation option on the manuscript-submission systems.‘We are really pleased to have already been conferred Fast Track status for ALKS 5461 as we think that ALKS 5461 may represent a significant option for the treating major depressive disorder,’ said Elliot Ehrich, Chief Medical Officer of Alkermes. ‘This designation supports our placement that there surely is a apparent and compelling need for a novel mechanism for the treating depression.’.. Acetylon announces positive preclinical data of ricolinostat in models of lymphoma Acetylon Pharmaceuticals, Inc., the first choice in the advancement of selective histone deacetylase inhibitors for improved therapeutic outcomes, announced that positive preclinical data of selective HDAC6 inhibitor, ricolinostat , today in an oral display by Dr in models of lymphoma were presented.